Five things you need to know about prostate cancer diagnostic tests
For many years, prostate cancer early detection was a straightforward matter of recommending biopsy to all men with an elevated prostate-specific antigen (PSA). This is perhaps best evidenced by the European Randomized Trial of Screening for Prostate Cancer, where an automatic biopsy is specified in the protocol and close to 90% of men with a PSA ≥3.0 ng/mL were biopsied [1]. Starting around 2010,